Although most studies revealed that the low expression of ACSL4 in lung cancer was a biomarker of adverse outcomes, some studies showed that the upregulation of ACSL4 gene may be one of the causes of lung cancer. The gene discussed is ACSL4; the disease is lung carcinoma.